logo
logo

Newcastle-Based Biotech Iksuda Therapeutics Secures £34M To Treat Haematological And Solid Tumours

Jun 07, 2021•about 4 years ago

Amount Raised

€34 Million

Newcastle

Description

Based out of Newcastle, Iksuda Therapeutics is a biotechnology company that specialises in the development of next-generation biotherapeutics.

Company Information

Company

Iksuda

Location

Newcastle, Washington, United States

About

Iksuda is an emerging biotechnology company focused on developing antibody-based therapies for the treatment of cancer as well as broader based therapeutics. Our main goal is to develop effective therapies to improve patients’ lives. Our mission is to enable improved clinical regimes through cre ...

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech